RA Capital Management

Ra Capital Management as of Dec. 31, 2023

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 62 positions in its portfolio as reported in the December 2023 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ascendis Pharma A/s - SH (ASND) 19.9 $1.3B 10M 125.95
Immunogen SH 11.0 $704M 24M 29.65
Vaxcyte SH (PCVX) 7.7 $496M 7.9M 62.80
Legend Biotech Corp- SH (LEGN) 5.9 $377M 6.3M 60.17
Rhythm Pharmaceuticals SH (RYTM) 3.8 $245M 5.3M 45.97
Aerovate Therapeutics SH (AVTE) 2.9 $187M 8.3M 22.63
Inhibrx SH 2.8 $180M 4.7M 38.00
Cymabay Therapeutics SH 2.6 $164M 6.9M 23.62
Biogen SH (BIIB) 2.2 $138M 533k 258.77
Rxsight SH (RXST) 2.1 $137M 3.4M 40.32
89bio SH (ETNB) 2.0 $128M 11M 11.17
Verona Pharma Plc - SH (VRNA) 2.0 $126M 6.3M 19.88
Day One Biopharmaceuticals I SH (DAWN) 1.8 $114M 7.8M 14.60
An2 Therapeutics SH (ANTX) 1.8 $114M 5.6M 20.49
Tyra Biosciences SH (TYRA) 1.6 $100M 7.2M 13.85
Janux Therapeutics SH (JANX) 1.5 $98M 9.2M 10.73
Geron Corp SH (GERN) 1.5 $98M 46M 2.11
Icosavax SH 1.5 $94M 6.0M 15.76
Alpine Immune Sciences SH 1.5 $94M 4.9M 19.06
Wave Life Sciences SH (WVE) 1.4 $92M 18M 5.05
Newamsterdam Pharma Co Nv SH (NAMS) 1.4 $88M 7.9M 11.17
4d Molecular Therapeutics In SH (FDMT) 1.3 $84M 4.2M 20.26
Evolent Health Inc - A SH (EVH) 1.3 $84M 2.5M 33.03
Axsome Therapeutics SH (AXSM) 1.2 $80M 1.0M 79.59
Fulcrum Therapeutics SH (FULC) 1.2 $78M 12M 6.75
Cytek Biosciences SH (CTKB) 1.0 $62M 6.8M 9.12
Acumen Pharmaceuticals SH (ABOS) 0.9 $57M 15M 3.84
Pepgen SH (PEPG) 0.9 $55M 8.1M 6.80
Apogee Therapeutics SH (APGE) 0.9 $55M 2.0M 27.94
Ars Pharmaceuticals SH (SPRY) 0.8 $52M 9.5M 5.48
Nkarta SH (NKTX) 0.8 $52M 7.8M 6.60
Vor Biopharma SH (VOR) 0.8 $51M 23M 2.25
Iteos Therapeutics SH (ITOS) 0.8 $48M 4.4M 10.95
Madrigal Pharmaceuticals SH (MDGL) 0.7 $47M 205k 231.38
Urogen Pharma SH (URGN) 0.7 $46M 3.1M 15.00
Macrogenics SH (MGNX) 0.6 $39M 4.1M 9.62
Eliem Therapeutics SH (CLYM) 0.6 $36M 13M 2.70
Taysha Gene Therapies SH (TSHA) 0.5 $33M 19M 1.77
Gh Research SH (GHRS) 0.5 $32M 5.6M 5.80
Enliven Therapeutics SH (ELVN) 0.5 $29M 2.1M 13.84
C4 Therapeutics SH (CCCC) 0.4 $28M 4.9M 5.65
Mineralys Therapeutics SH (MLYS) 0.4 $27M 3.2M 8.60
Werewolf Therapeutics SH (HOWL) 0.4 $24M 6.1M 3.86
Acrivon Therapeutics SH (ACRV) 0.4 $24M 4.8M 4.92
Pliant Therapeutics SH (PLRX) 0.4 $23M 1.3M 18.11
Third Harmonic Bio SH (THRD) 0.3 $22M 2.0M 10.97
Avidity Biosciences SH (RNA) 0.3 $22M 2.5M 9.05
Solid Biosciences SH (SLDB) 0.3 $21M 3.4M 6.14
Structure Therapeutics SH (GPCR) 0.3 $20M 487k 40.76
Tenaya Therapeutics SH (TNYA) 0.3 $18M 5.5M 3.24
Arvinas SH (ARVN) 0.3 $17M 421k 41.16
Harpoon Therapeutics SH 0.3 $17M 1.5M 11.37
Bicycle Therapeutics Plc- SH (BCYC) 0.2 $15M 800k 18.08
Curevac Nv SH (CVAC) 0.2 $12M 2.7M 4.21
Compass Pathways SH (CMPS) 0.2 $11M 1.3M 8.75
Black Diamond Therapeutics I SH (BDTX) 0.2 $9.9M 3.5M 2.81
Chimerix SH (CMRX) 0.1 $8.5M 8.8M 0.96
Igm Biosciences SH (IGMS) 0.1 $7.8M 938k 8.31
Connect Biopharma Holdings L SH (CNTB) 0.1 $3.6M 3.1M 1.18
Unicycive Therapeutics SH (UNCY) 0.0 $3.0M 3.5M 0.87
Sab Biotherapeutics SH (SABS) 0.0 $1.6M 2.4M 0.69
Newamsterdam Pharma Co Nv-27 SH (NAMSW) 0.0 $1.0M 333k 3.13